Professor Liam Grover is a Professor in Biomaterials Science and the Director of the Healthcare Technologies Institute, an interdisciplinary network of over 70 academics working together to advance new technologies and treatments that encourage better tissue healing and rehabilitation tools. The HTI brings together leading experts from a variety of disciplines across the University of Birmingham, including chemical engineering, biomedical science, computer science, applied mathematics, chemistry and physics. Researchers across campus are working collaboratively to speed up the translation of new discoveries into health applications.
Professor Grover is a materials scientist by training, and completed his PhD at the University of Birmingham before moving to McGill University (Montreal) to work as a CIHR skeletal health scholar. He returned to Birmingham in 2006 to establish a research group within the School of Chemical Engineering.
He has published widely on the development of new materials to replace the function of tissues (more than 180 papers) and has filed more than ten patents to protect technologies that range from osteogenic cements through to scar reducing dressings. He has given well over 50 invited talks outside the UK. Since starting his career, he has moved three technologies from concept through to clinical trial.
Since returning to Birmingham, he has raised over £30m to fund his research on the development and translation of novel medical technologies (EPSRC, MRC, BBSRC, ERDF, EU, NC3Rs, NSFC – China, NIHR, RCDM, and industry) and is the Founder-Director of the Healthcare Technologies Institute, which works to help move novel technologies through the translational pipeline. He sits on the EPSRC Healthcare Technologies SAT, the NIHR i4i panel and has sat on the MRC DPFS panel.
He was the youngest Professor in the history of the University of Birmingham (32) and the youngest ever Fellow of the Institute of Materials (30).
Get in touch